Sponsors (31)
The bill expands routine, standardized cognitive screening to improve early detection, care coordination, and prevention attention for Alzheimer’s and dementia—but it also increases fiscal pressure, raises potential out‑of‑pocket and administrative burdens, and risks exacerbating disparities and privacy concerns unless paired with funding, reimbursement, and equity safeguards.
Medicare beneficiaries will receive routine cognitive screening at annual wellness visits (AWVs) and initial preventive physical exams (IPPEs) starting Jan 1, 2026, increasing early detection of dementia and cognitive decline.
Primary care clinicians must use and document NIA‑identified screening tools and results, creating standardized assessments and better documented referrals/continuity of care across health systems.
Seniors with dementia and their families—including unpaid caregivers—are more likely to receive greater attention, support planning, and justification for caregiver services and respite as the bill highlights the scale and cost of Alzheimer’s.
Federal spending pressures could grow as Alzheimer’s care costs are projected to rise (approaching $1.1 trillion by 2050), creating budgetary pressure on Medicare and Medicaid and potential calls for increased taxpayer funding.
Patients and families may face higher out‑of‑pocket costs absent policy changes, since current out‑of‑pocket spending for dementia care is large (≈$91 billion) and greater diagnosis/utilization could increase these burdens.
Primary care clinicians and clinics will face added administrative burden, documentation requirements, and potentially uncompensated screening time, which could increase visit workload or reduce clinic capacity.
Based on analysis of 2 sections of legislative text.
Requires NIA‑listed cognitive impairment detection tools and documentation during Medicare AWVs and IPPEs, effective Jan 1, 2026.
Introduced May 19, 2025 by Linda T. Sánchez · Last progress May 19, 2025
Requires Medicare preventive visits to include screening for cognitive impairment using tools the National Institute on Aging (NIA) has identified as meeting primary-care selection criteria, and requires clinicians to record which tool was used and the assessment results in the medical record. Also states congressional findings about the scope, costs, disparities, preventable risk factors, and caregiving burden associated with Alzheimer’s disease and related dementias.